http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2192280-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a76005674ca674f56255efc2e936067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f0ccf8ac62cc5ef73e096f1c73e3c0c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2001-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71e8e0573d7855cb845c2e1900d0db6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aef9b92c72861a8198cab6a5ecb46f77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58a7d0527ee340eb3f61615507a06d6e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be1dddf966bd44efcef454e8e8f732a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f96eb7e3e07d4e5db5cdc67d97bd23c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2214c9347e330ddbb4eb1c41ba10a38 |
| publicationDate | 2002-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2192280-C1 |
| titleOfInvention | Method of immunoglobulin preparation preparing |
| abstract | FIELD: medicine, immunology. SUBSTANCE: alcohol precipitate B of human plasma blood is diluted in 15- 20 volumes of 0.005-0.01 M sodium chloride solution at pH 5.3-5.6, ethyl alcohol is added to final concentration 13-17% at temperature (0 C) (-4 C), precipitate is separated, pH value is brought about to 6.8-7.2 and ethyl alcohol is added to final concentration 24-26%. Precipitate is separated by centrifugation, dissolved in 10-15 volumes of 0.005-0.01 M sodium chloride solution at pH 5.3-5.6 and ethyl alcohol is added to final concentration 13-17%. Inert precipitate is separated by centrifugation, pH value of supernatant is brought about to 6.9 ± 01 and ethyl alcohol is added to final concentration 24-26% at temperature (-4 C) (-10 C). Precipitate of end product is isolated by centrifugation, dissolved in water followed by sterilizing filtration and solution is kept at temperature (+1 C) (+15 C) for 1 week 1 month. Precipitate is removed by sterilizing filtration and low-molecular impurities are removed by ultrafiltration. Invention can be used for immunotherapy and immunoprophylaxis of bacterial and viral infections. EFFECT: enhanced purity degree of end product. 2 ex |
| priorityDate | 2001-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.